Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wansbrough-Jones

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|December 5, 2015
Metabolomic profiles delineate mycolactone signature in Buruli ulcer diseaseFatoumata Niang, Fred S Sarfo, Michael Frimpong, et al.
Plos Neglected Tropical Diseases|February 2, 2019
Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assayMichael Frimpong, Hubert Senanu Ahor, Ahmed Abd El Wahed, et al.
Plos Neglected Tropical Diseases|February 21, 2025
A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infectionJustice Kofi Boakye-Appiah, Andy C Tran, Matthew J Paul, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans diseaseRichard O Phillips, Fred S Sarfo, Mohammed K Abass, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Reply to "compliance with antimicrobial therapy for buruli ulcer"Richard O Phillips, Fred S Sarfo, Mohammed K Abass, et al.
Plos Neglected Tropical Diseases|April 12, 2014
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer diseaseRichard O Phillips, Fred S Sarfo, Jordi Landier, et al.
Plos Neglected Tropical Diseases|November 20, 2015
Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer ChromatographyAnita Wadagni, Michael Frimpong, Delphin Mavinga Phanzu, et al.
Plos Neglected Tropical Diseases|August 4, 2011
Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoringFred S Sarfo, Fabien Le Chevalier, N'Guetta Aka, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 22, 2024
Bacterial diversity in Buruli ulcer lesions in GhanaNancy Ackam, Abigail Opoku-Boadi, Bernadette Agbavor, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 31, 2024
Clinical and microbiological predictors of healing in Buruli ulcer diseaseBernadette Agbavor, Abigail Agbanyo, Aloysius Dzigbordi Loglo, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|December 5, 2015
Metabolomic profiles delineate mycolactone signature in Buruli ulcer diseaseFatoumata Niang, Fred S Sarfo, Michael Frimpong, et al.
Plos Neglected Tropical Diseases|February 2, 2019
Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assayMichael Frimpong, Hubert Senanu Ahor, Ahmed Abd El Wahed, et al.
Plos Neglected Tropical Diseases|February 21, 2025
A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infectionJustice Kofi Boakye-Appiah, Andy C Tran, Matthew J Paul, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans diseaseRichard O Phillips, Fred S Sarfo, Mohammed K Abass, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Reply to "compliance with antimicrobial therapy for buruli ulcer"Richard O Phillips, Fred S Sarfo, Mohammed K Abass, et al.
Plos Neglected Tropical Diseases|April 12, 2014
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer diseaseRichard O Phillips, Fred S Sarfo, Jordi Landier, et al.
Plos Neglected Tropical Diseases|November 20, 2015
Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer ChromatographyAnita Wadagni, Michael Frimpong, Delphin Mavinga Phanzu, et al.
Plos Neglected Tropical Diseases|August 4, 2011
Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoringFred S Sarfo, Fabien Le Chevalier, N'Guetta Aka, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 22, 2024
Bacterial diversity in Buruli ulcer lesions in GhanaNancy Ackam, Abigail Opoku-Boadi, Bernadette Agbavor, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 31, 2024
Clinical and microbiological predictors of healing in Buruli ulcer diseaseBernadette Agbavor, Abigail Agbanyo, Aloysius Dzigbordi Loglo, et al.
Pageof 4